News Analysis DOD cancer research programs face 57% funding cut in year-long continuing resolutionPancreatic, lung, kidney cancer research programs eliminated March 28, 2025Vol.51 No.12By Jacquelyn Cobb
Guest Editorial Rathmell: We must support our junior colleagues“Empathy and listening is a key place to start” March 28, 2025Vol.51 No.12By W. Kimryn Rathmell
Guest Editorial Weill Cancer Hub East to investigate connections between metabolism and anti-tumor immunityWeill Cornell, Rockefeller, Princeton and the Ludwig Institute for Cancer Research showcase the power of collaboration March 28, 2025Vol.51 No.12By Jedd D. Wolchok, Joshua D. Rabinowitz and Sohail Tavazoie
Sponsored Building a nationally integrated cancer research and treatment network March 28, 2025Vol.51 No.12By Edward S. Kim
FreeIn the Archives Breast cancer activists in the 90s got DOD to fund cancer research—now that program has been gutted March 28, 2025Vol.51 No.12
News Analysis Trump’s tariffs will likely affect cancer drugs and devices—and may deepen drug shortages March 21, 2025Vol.51 No.11By Claire Marie Porter and Jacquelyn Cobb
Guest Editorial Caught in the crossfire: The critical threats facing cancer centers, research, and patient care March 21, 2025Vol.51 No.11By Shannon McWeeney and Sorena Nadaf-Rahrov
White House Columbia’s cancer center becomes collateral damage in Trump’s war on antisemitism March 21, 2025Vol.51 No.11By Paul Goldberg
Guest Editorial Rathmell: We need a “March Madness” for cancer research“Cancer is a tremendously challenging tournament, but we are in it to win” March 21, 2025Vol.51 No.11By W. Kimryn Rathmell
Guest Editorial Health innovation and health equity: Ensuring technologies advance resilience, justice, and compassionate care March 21, 2025Vol.51 No.11By Jamillah Hoy-Rosas
